What To Know: This certification will allow the company to continue to export medically certified cannabis to European medical markets and various other medical cannabis markets globally. It is also significant as it marks the completion of Canopy's consolidation of its production footprint into two purpose-built sites.
Related Link: Microsoft's AI Alignment Boosts Investor Confidence According to Morgan Stanley
CGC Price Action: Shares of CGC were up 5.09% at $0.72 at the time of publication, according to Benzinga Pro.
Image by 7raysmarketing from Pixabay
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
